Zobrazeno 1 - 9
of 9
pro vyhledávání: '"R. J. X. M. Van Etten"'
A single drug for Helicobacter pylori infection: first results with a new bismuth triple monocapsule
Publikováno v:
The American Journal of Gastroenterology. 95:641-645
In this pilot study we investigated the efficacy and tolerability of a new monocapsule that contains a bismuth compound, tetracycline, and metronidazole. If proven to be effective, this monotherapy would turn the well-accepted multidrug regimen of st
Autor:
Jan B.M.J. Jansen, Peter M. Schneeberger, B.A.M. van de Wouw, R. J. X. M. Van Etten, A.H.A.M. van Oijen, W. A. De Boer
Publikováno v:
Alimentary Pharmacology & Therapeutics. 14:85-89
Background: Recently a new ‘all in one’ single capsule with the three components of bismuth-based triple therapy became available in trials for treating Helicobacter pylori. Aim: To investigate the efficacy and tolerability of this new capsule wh
Publikováno v:
Alimentary Pharmacology & Therapeutics. 12:77-81
Background: The very high cure rate of 1-week quadruple therapy offers an opportunity to study a shorter treatment duration. This is needed to construct a time–response curve for the regimen. Methods: Fifty-two patients with endoscopically proven H
Publikováno v:
The Netherlands Journal of Medicine. 52:10-15
Background: Ulcer patients need to be treated for Helicobacter pylori infection. Seven days of quadruple therapy achieves the highest cure rates. In this study a 4-day quadruple regimen of lansoprazole, bismuth, tetracycline and metronidazole is inve
Autor:
Guido N. J. Tytgat, A. J. M. Van Unnik, M. E. Ouwehand, W. A. De Boer, Peter M. Schneeberger, R. J. X. M. Van Etten, R. W. B. Schade
Publikováno v:
Alimentary pharmacology & therapeutics, 11(1), 109-112. Wiley-Blackwell
Alimentary pharmacology & therapeutics, 11, 109-112. Wiley-Blackwell
Alimentary pharmacology & therapeutics, 11, 109-112. Wiley-Blackwell
Background: Peptic ulcer patients need to be treated with antimicrobials to cure Helicobacter pylori infection. Seven-day quadruple therapy is the regimen with the highest cure rates. An ultra-short quadruple therapy was evaluated prospectively. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a9cbc5feebc71fbea4f59a4fd25755c
https://pure.amc.nl/en/publications/oneday-intensified-lansoprazolequadruple-therapy-for-cure-of-helicobacter-pylori-infection(07620860-aa75-4c00-8866-01ceb7250676).html
https://pure.amc.nl/en/publications/oneday-intensified-lansoprazolequadruple-therapy-for-cure-of-helicobacter-pylori-infection(07620860-aa75-4c00-8866-01ceb7250676).html
Autor:
Geboes, K.1 (AUTHOR), Dekker, W.2 (AUTHOR), Mulder, C. J. J.3 (AUTHOR), Nusteling, K.4 (AUTHOR)
Publikováno v:
Alimentary Pharmacology & Therapeutics. Nov2001, Vol. 15 Issue 11, p1819-1826. 8p.
Autor:
Boer, W. A. De1 (AUTHOR), Etten, R. J. X. M. Van1 (AUTHOR), Coremans1 (AUTHOR), Schneeberger2 (AUTHOR)
Publikováno v:
Alimentary Pharmacology & Therapeutics. Jan1998, Vol. 12 Issue 1, p77-81. 5p.
Publikováno v:
Alimentary Pharmacology & Therapeutics; Aug1993, Vol. 7 Issue 4, p409-415, 7p
Publikováno v:
American Journal of Gastroenterology (Springer Nature); Sep1996, Vol. 91 Issue 9, preceding p1689-1689, 3p